{"id": "R45405", "inputs": [{"text": "on october 24 , 2018 , president trump signed into law h.r .", "tokens": ["on", "october", "24", ",", "2018", ",", "president", "trump", "signed", "into", "law", "h.r", "."], "sentence_id": 1, "word_count": 13}, {"text": "6 , the substance use - disorder prevention that promotes opioid recovery and treatment for patients and communities act ( p.l .", "tokens": ["6", ",", "the", "substance", "use", "-", "disorder", "prevention", "that", "promotes", "opioid", "recovery", "and", "treatment", "for", "patients", "and", "communities", "act", "(", "p.l", "."], "sentence_id": 2, "word_count": 22}, {"text": "115-271 ; the support for patients and communities act , or the support act ) .", "tokens": ["115-271", ";", "the", "support", "for", "patients", "and", "communities", "act", ",", "or", "the", "support", "act", ")", "."], "sentence_id": 3, "word_count": 16}, {"text": "the final agreement on the bill was approved by the house 393-8 on s eptember 28 , 2018 , and cleared the senate by 98-1 on october 3 , 2018 .", "tokens": ["the", "final", "agreement", "on", "the", "bill", "was", "approved", "by", "the", "house", "393-8", "on", "s", "eptember", "28", ",", "2018", ",", "and", "cleared", "the", "senate", "by", "98-1", "on", "october", "3", ",", "2018", "."], "sentence_id": 4, "word_count": 31}, {"text": "over the past several years , there has been growing concern among the public and lawmakers in the united states about rising drug overdose deaths .", "tokens": ["over", "the", "past", "several", "years", ",", "there", "has", "been", "growing", "concern", "among", "the", "public", "and", "lawmakers", "in", "the", "united", "states", "about", "rising", "drug", "overdose", "deaths", "."], "sentence_id": 5, "word_count": 26}, {"text": "opioid overdose deaths , in particular , have increased significantly in the past 15 years .", "tokens": ["opioid", "overdose", "deaths", ",", "in", "particular", ",", "have", "increased", "significantly", "in", "the", "past", "15", "years", "."], "sentence_id": 6, "word_count": 16}, {"text": "in 2015 , an estimated 33,091 americans died of opioid - related overdoses , almost three times as many as in 2002 around the beginning of the epidemic .", "tokens": ["in", "2015", ",", "an", "estimated", "33,091", "americans", "died", "of", "opioid", "-", "related", "overdoses", ",", "almost", "three", "times", "as", "many", "as", "in", "2002", "around", "the", "beginning", "of", "the", "epidemic", "."], "sentence_id": 7, "word_count": 29}, {"text": "in 2016 , that number increased to 42,249 .", "tokens": ["in", "2016", ",", "that", "number", "increased", "to", "42,249", "."], "sentence_id": 8, "word_count": 9}, {"text": "in october 2017 , president trump declared the opioid epidemic a national public health emergency .", "tokens": ["in", "october", "2017", ",", "president", "trump", "declared", "the", "opioid", "epidemic", "a", "national", "public", "health", "emergency", "."], "sentence_id": 9, "word_count": 16}, {"text": "the support act is a sweeping measure designed to address widespread overprescribing and abuse of opioids in the united states .", "tokens": ["the", "support", "act", "is", "a", "sweeping", "measure", "designed", "to", "address", "widespread", "overprescribing", "and", "abuse", "of", "opioids", "in", "the", "united", "states", "."], "sentence_id": 10, "word_count": 21}, {"text": "the act includes provisions involving law enforcement , public health , and health care financing and coverage .", "tokens": ["the", "act", "includes", "provisions", "involving", "law", "enforcement", ",", "public", "health", ",", "and", "health", "care", "financing", "and", "coverage", "."], "sentence_id": 11, "word_count": 18}, {"text": "broadly , the legislation imposes tighter oversight of opioid production and distribution ; imposes additional reporting and safeguards to address fraud ; and limits coverage of prescription opioids , while expanding coverage of and access to opioid addiction treatment services .", "tokens": ["broadly", ",", "the", "legislation", "imposes", "tighter", "oversight", "of", "opioid", "production", "and", "distribution", ";", "imposes", "additional", "reporting", "and", "safeguards", "to", "address", "fraud", ";", "and", "limits", "coverage", "of", "prescription", "opioids", ",", "while", "expanding", "coverage", "of", "and", "access", "to", "opioid", "addiction", "treatment", "services", "."], "sentence_id": 12, "word_count": 41}, {"text": "the bill also authorizes a number of programs that seek to expand consumer education on opioid use and train additional providers to treat individuals with opioid use disorders .", "tokens": ["the", "bill", "also", "authorizes", "a", "number", "of", "programs", "that", "seek", "to", "expand", "consumer", "education", "on", "opioid", "use", "and", "train", "additional", "providers", "to", "treat", "individuals", "with", "opioid", "use", "disorders", "."], "sentence_id": 13, "word_count": 29}, {"text": "fda , pursuant to its authority under the federal food , drug , and cosmetic act ( ffdca ) , is responsible for ensuring the safety and effectiveness of prescription and nonprescription drugs sold in the united states , regardless of whether they are controlled substances .", "tokens": ["fda", ",", "pursuant", "to", "its", "authority", "under", "the", "federal", "food", ",", "drug", ",", "and", "cosmetic", "act", "(", "ffdca", ")", ",", "is", "responsible", "for", "ensuring", "the", "safety", "and", "effectiveness", "of", "prescription", "and", "nonprescription", "drugs", "sold", "in", "the", "united", "states", ",", "regardless", "of", "whether", "they", "are", "controlled", "substances", "."], "sentence_id": 14, "word_count": 47}, {"text": "fda regulates the full life - cycle of a drug product , starting with drug development , through the approval process , and then for as long as the product remains on the market .", "tokens": ["fda", "regulates", "the", "full", "life", "-", "cycle", "of", "a", "drug", "product", ",", "starting", "with", "drug", "development", ",", "through", "the", "approval", "process", ",", "and", "then", "for", "as", "long", "as", "the", "product", "remains", "on", "the", "market", "."], "sentence_id": 15, "word_count": 35}, {"text": "subtitle a addresses fda medical product regulation and includes provisions that , among other things , facilitate the development of new medical products for treatment of pain ; provide for special packaging and disposal mechanisms for opioids ; and amend postmarket study and labeling requirements .", "tokens": ["subtitle", "a", "addresses", "fda", "medical", "product", "regulation", "and", "includes", "provisions", "that", ",", "among", "other", "things", ",", "facilitate", "the", "development", "of", "new", "medical", "products", "for", "treatment", "of", "pain", ";", "provide", "for", "special", "packaging", "and", "disposal", "mechanisms", "for", "opioids", ";", "and", "amend", "postmarket", "study", "and", "labeling", "requirements", "."], "sentence_id": 16, "word_count": 46}, {"text": "the dea , under the controlled substances act ( csa ) , has primary responsibility for regulating the use of controlled substances for legitimate medical , scientific , research , and industrial purposes , and for preventing these substances from being diverted for illegal purposes .", "tokens": ["the", "dea", ",", "under", "the", "controlled", "substances", "act", "(", "csa", ")", ",", "has", "primary", "responsibility", "for", "regulating", "the", "use", "of", "controlled", "substances", "for", "legitimate", "medical", ",", "scientific", ",", "research", ",", "and", "industrial", "purposes", ",", "and", "for", "preventing", "these", "substances", "from", "being", "diverted", "for", "illegal", "purposes", "."], "sentence_id": 17, "word_count": 46}, {"text": "while the ffdca requires that certain drugs be dispensed only pursuant to a prescription from a health care provider , the csa sets forth requirements for dispensing controlled substances specifically .", "tokens": ["while", "the", "ffdca", "requires", "that", "certain", "drugs", "be", "dispensed", "only", "pursuant", "to", "a", "prescription", "from", "a", "health", "care", "provider", ",", "the", "csa", "sets", "forth", "requirements", "for", "dispensing", "controlled", "substances", "specifically", "."], "sentence_id": 18, "word_count": 31}, {"text": "subtitle b addresses dea regulation of controlled substances and includes provisions that , among other things , provide additional flexibility with respect to medication - assisted treatment ( mat ) for opioid use disorders ; modify controlled substances disposal requirements at qualified hospice programs ; and authorize grants to states to increase participation of eligible collectors in drug - disposal programs .", "tokens": ["subtitle", "b", "addresses", "dea", "regulation", "of", "controlled", "substances", "and", "includes", "provisions", "that", ",", "among", "other", "things", ",", "provide", "additional", "flexibility", "with", "respect", "to", "medication", "-", "assisted", "treatment", "(", "mat", ")", "for", "opioid", "use", "disorders", ";", "modify", "controlled", "substances", "disposal", "requirements", "at", "qualified", "hospice", "programs", ";", "and", "authorize", "grants", "to", "states", "to", "increase", "participation", "of", "eligible", "collectors", "in", "drug", "-", "disposal", "programs", "."], "sentence_id": 19, "word_count": 62}, {"text": "the drug price competition and patent term restoration act of 1984 ( hatch - waxman act ; p.l .", "tokens": ["the", "drug", "price", "competition", "and", "patent", "term", "restoration", "act", "of", "1984", "(", "hatch", "-", "waxman", "act", ";", "p.l", "."], "sentence_id": 20, "word_count": 19}, {"text": "98-417 ) created an abbreviated pathway for generic drugs , allowing a generic drug manufacturer to submit to fda an abbreviated nda ( i.e. , an anda ) , rather than a full nda , demonstrating that the generic product is the same as the brand drug ( i.e. , the rld ) .", "tokens": ["98-417", ")", "created", "an", "abbreviated", "pathway", "for", "generic", "drugs", ",", "allowing", "a", "generic", "drug", "manufacturer", "to", "submit", "to", "fda", "an", "abbreviated", "nda", "(", "i.e", ".", ",", "an", "anda", ")", ",", "rather", "than", "a", "full", "nda", ",", "demonstrating", "that", "the", "generic", "product", "is", "the", "same", "as", "the", "brand", "drug", "(", "i.e", ".", ",", "the", "rld", ")", "."], "sentence_id": 21, "word_count": 56}, {"text": "by relying on fda's previous determination that the rld is safe and effective , the generic drug company can avoid replicating the expensive clinical trials already conducted by the brand company .", "tokens": ["by", "relying", "on", "fda", "'s", "previous", "determination", "that", "the", "rld", "is", "safe", "and", "effective", ",", "the", "generic", "drug", "company", "can", "avoid", "replicating", "the", "expensive", "clinical", "trials", "already", "conducted", "by", "the", "brand", "company", "."], "sentence_id": 22, "word_count": 33}, {"text": "the generic drug applicant must , among other things , submit either a section viii statement or one of four certifications for every patent listed in the orange book with respect to the rld referenced in the anda: the brand company has not filed any patent information with respect to the rld ; the patent has expired ; the date on which the patent will expire ; or the patent is invalid or will not be infringed by the drug for which the anda is submitted , as specified .", "tokens": ["the", "generic", "drug", "applicant", "must", ",", "among", "other", "things", ",", "submit", "either", "a", "section", "viii", "statement", "or", "one", "of", "four", "certifications", "for", "every", "patent", "listed", "in", "the", "orange", "book", "with", "respect", "to", "the", "rld", "referenced", "in", "the", "anda", ":", "the", "brand", "company", "has", "not", "filed", "any", "patent", "information", "with", "respect", "to", "the", "rld", ";", "the", "patent", "has", "expired", ";", "the", "date", "on", "which", "the", "patent", "will", "expire", ";", "or", "the", "patent", "is", "invalid", "or", "will", "not", "be", "infringed", "by", "the", "drug", "for", "which", "the", "anda", "is", "submitted", ",", "as", "specified", "."], "sentence_id": 23, "word_count": 91}, {"text": "these are referred to as paragraph i , ii , iii , and iv certifications , respectively .", "tokens": ["these", "are", "referred", "to", "as", "paragraph", "i", ",", "ii", ",", "iii", ",", "and", "iv", "certifications", ",", "respectively", "."], "sentence_id": 24, "word_count": 18}, {"text": "the first generic drug company that files an anda with a paragraph iv certification is eligible to receive a 180-day period of exclusivity , which precludes fda from approving another anda for the same product during that period of time .", "tokens": ["the", "first", "generic", "drug", "company", "that", "files", "an", "anda", "with", "a", "paragraph", "iv", "certification", "is", "eligible", "to", "receive", "a", "180-day", "period", "of", "exclusivity", ",", "which", "precludes", "fda", "from", "approving", "another", "anda", "for", "the", "same", "product", "during", "that", "period", "of", "time", "."], "sentence_id": 25, "word_count": 41}, {"text": "since enactment of hatch - waxman , certain practices have emerged that may disrupt the law's intended balance between innovation and competition in the pharmaceutical industry .", "tokens": ["since", "enactment", "of", "hatch", "-", "waxman", ",", "certain", "practices", "have", "emerged", "that", "may", "disrupt", "the", "law", "'s", "intended", "balance", "between", "innovation", "and", "competition", "in", "the", "pharmaceutical", "industry", "."], "sentence_id": 26, "word_count": 28}, {"text": "one such practice involves pay - for - delay settlements pursuant to which a generic drug company agrees to neither challenge a brand company's patents nor sell a generic version of a patented rld for a certain period of time in exchange for payment from the brand company .", "tokens": ["one", "such", "practice", "involves", "pay", "-", "for", "-", "delay", "settlements", "pursuant", "to", "which", "a", "generic", "drug", "company", "agrees", "to", "neither", "challenge", "a", "brand", "company", "'s", "patents", "nor", "sell", "a", "generic", "version", "of", "a", "patented", "rld", "for", "a", "certain", "period", "of", "time", "in", "exchange", "for", "payment", "from", "the", "brand", "company", "."], "sentence_id": 27, "word_count": 50}, {"text": "title xi of the medicare prescription drug , improvement , and modernization act of 2003 ( mma ; p.l .", "tokens": ["title", "xi", "of", "the", "medicare", "prescription", "drug", ",", "improvement", ",", "and", "modernization", "act", "of", "2003", "(", "mma", ";", "p.l", "."], "sentence_id": 28, "word_count": 20}, {"text": "108-173 ) required drug companies to file such agreements with the federal trade commission ( ftc ) and doj .", "tokens": ["108-173", ")", "required", "drug", "companies", "to", "file", "such", "agreements", "with", "the", "federal", "trade", "commission", "(", "ftc", ")", "and", "doj", "."], "sentence_id": 29, "word_count": 20}, {"text": "more specifically , under mma section 1112 ( a ) , a generic drug company that submits an anda containing a paragraph iv certification and a brand drug company that enter into an agreement must each file the agreement with ftc and doj .", "tokens": ["more", "specifically", ",", "under", "mma", "section", "1112", "(", "a", ")", ",", "a", "generic", "drug", "company", "that", "submits", "an", "anda", "containing", "a", "paragraph", "iv", "certification", "and", "a", "brand", "drug", "company", "that", "enter", "into", "an", "agreement", "must", "each", "file", "the", "agreement", "with", "ftc", "and", "doj", "."], "sentence_id": 30, "word_count": 44}, {"text": "covered agreements are those regarding the manufacture , marketing , or sale of the rld that is listed in the anda or the generic drug for which the anda was submitted , as well as agreements regarding the 180-day exclusivity period as it applies to the anda or to any other anda based on the same rld .", "tokens": ["covered", "agreements", "are", "those", "regarding", "the", "manufacture", ",", "marketing", ",", "or", "sale", "of", "the", "rld", "that", "is", "listed", "in", "the", "anda", "or", "the", "generic", "drug", "for", "which", "the", "anda", "was", "submitted", ",", "as", "well", "as", "agreements", "regarding", "the", "180-day", "exclusivity", "period", "as", "it", "applies", "to", "the", "anda", "or", "to", "any", "other", "anda", "based", "on", "the", "same", "rld", "."], "sentence_id": 31, "word_count": 58}, {"text": "additionally , under mma section 1112 ( b ) , if two generic drug applicants each have submitted an anda containing a paragraph iv certification for the same rld , and they have entered into an agreement regarding the 180-day exclusivity period , each applicant is required to file the agreement with ftc and doj .", "tokens": ["additionally", ",", "under", "mma", "section", "1112", "(", "b", ")", ",", "if", "two", "generic", "drug", "applicants", "each", "have", "submitted", "an", "anda", "containing", "a", "paragraph", "iv", "certification", "for", "the", "same", "rld", ",", "and", "they", "have", "entered", "into", "an", "agreement", "regarding", "the", "180-day", "exclusivity", "period", ",", "each", "applicant", "is", "required", "to", "file", "the", "agreement", "with", "ftc", "and", "doj", "."], "sentence_id": 32, "word_count": 56}, {"text": "mma section 1112 ( c ) requires drug companies also to file agreements not described in subsections ( a ) and ( b ) of section 1112 if they are contingent upon , provide a contingent condition for , or are otherwise related to ( a ) or ( b ) agreements .", "tokens": ["mma", "section", "1112", "(", "c", ")", "requires", "drug", "companies", "also", "to", "file", "agreements", "not", "described", "in", "subsections", "(", "a", ")", "and", "(", "b", ")", "of", "section", "1112", "if", "they", "are", "contingent", "upon", ",", "provide", "a", "contingent", "condition", "for", ",", "or", "are", "otherwise", "related", "to", "(", "a", ")", "or", "(", "b", ")", "agreements", "."], "sentence_id": 33, "word_count": 53}, {"text": "the patient right to know drug prices act ( p.l .", "tokens": ["the", "patient", "right", "to", "know", "drug", "prices", "act", "(", "p.l", "."], "sentence_id": 34, "word_count": 11}, {"text": "115-263 ) amended mma title xi , expanding these reporting requirements to include agreements between biosimilar product applicants and brand companies , as well as agreements between two biosimilar product applicants .", "tokens": ["115-263", ")", "amended", "mma", "title", "xi", ",", "expanding", "these", "reporting", "requirements", "to", "include", "agreements", "between", "biosimilar", "product", "applicants", "and", "brand", "companies", ",", "as", "well", "as", "agreements", "between", "two", "biosimilar", "product", "applicants", "."], "sentence_id": 35, "word_count": 32}, {"text": "section 4004 amends mma title xi , further expanding reporting requirements to include agreements between two or more generic drug applicants and between two or more biosimilar product applicants , as well as other agreements not described under subsections ( a ) and ( b ) of mma section 1112 , but that were entered into within 30 days of ( a ) or ( b ) agreements .", "tokens": ["section", "4004", "amends", "mma", "title", "xi", ",", "further", "expanding", "reporting", "requirements", "to", "include", "agreements", "between", "two", "or", "more", "generic", "drug", "applicants", "and", "between", "two", "or", "more", "biosimilar", "product", "applicants", ",", "as", "well", "as", "other", "agreements", "not", "described", "under", "subsections", "(", "a", ")", "and", "(", "b", ")", "of", "mma", "section", "1112", ",", "but", "that", "were", "entered", "into", "within", "30", "days", "of", "(", "a", ")", "or", "(", "b", ")", "agreements", "."], "sentence_id": 36, "word_count": 69}, {"text": "section 4004 also makes numerous technical changes to mma title xi , as amended by p.l .", "tokens": ["section", "4004", "also", "makes", "numerous", "technical", "changes", "to", "mma", "title", "xi", ",", "as", "amended", "by", "p.l", "."], "sentence_id": 37, "word_count": 17}, {"text": "115-263 .", "tokens": ["115-263", "."], "sentence_id": 38, "word_count": 2}, {"text": "this section applies to taxable years beginning after december 31 , 2018 .", "tokens": ["this", "section", "applies", "to", "taxable", "years", "beginning", "after", "december", "31", ",", "2018", "."], "sentence_id": 39, "word_count": 13}, {"text": "the cbo estimates that this provision would decrease direct spending outlays by $41 million from fy2019 through fy2028 .", "tokens": ["the", "cbo", "estimates", "that", "this", "provision", "would", "decrease", "direct", "spending", "outlays", "by", "$", "41", "million", "from", "fy2019", "through", "fy2028", "."], "sentence_id": 40, "word_count": 20}, {"text": "the table below includes relevant provisions that include a required report , guidance , or other action , listed in order of section number .", "tokens": ["the", "table", "below", "includes", "relevant", "provisions", "that", "include", "a", "required", "report", ",", "guidance", ",", "or", "other", "action", ",", "listed", "in", "order", "of", "section", "number", "."], "sentence_id": 41, "word_count": 25}], "section_names": ["", "introduction", "title iii\u2014fda and controlled substance provisions", "subtitle a\u2014fda provisions", "subtitle b\u2014controlled substance provisions", "title iv\u2014offsets", "section 4004. modernizing the reporting of biological and biosimilar products", "background", "provision", "appendix. fda and controlled substances provisions with implementation deadlines"], "section_lengths": [0, 13, 0, 3, 3, 0, 0, 16, 5, 1]}